Chuanbin Mao
The Chinese University of Hong Kong, China

Chuanbin Mao received his Ph.D. from Northeastern University (China), and completed postdoctoral studies at Tsinghua University and University of Texas at Austin. He was promoted from assistant professor to full professor at the University of Oklahoma. He recently joined Department of Biomedical Engineering of the Chinese University of Hong Kong as a Global STEM Scholar bestowed by Hong Kong Government. His research is focused on natural and synthetic biopolymers, with an emphasis on genetic engineering of phages to develop novel strategies for biomaterials, nanobiotechnology, nanomedicine, and regenerative medicine. He has genetically engineered phages for successfully assembling nanoparticles (Science 2002 and 2004), seeking cell-/tissue-targeting peptides (Advanced Materials 2020), detecting biomarkers for cancer diagnosis (Nature Materials 2015), inducing stem cell differentiation (Advanced Materials 2019), promoting drug/gene delivery (Angewandte Chemie 2013) and tissue regeneration (Advanced Materials 2014 and 2022), and developing nano-theranostic agents (Materials Horizons 2019). He has created biopolymers and hydrogels for effectively regenerating tissues such as penile tissue (Nature Communications 2020) and cartilage (Nature Biomedical Engineering 2021) and invented a way of optimizing biomolecular distribution on medical implants (Nature Communications, 2021). He has published 1 book, 11 book chapters, and ~280 journal articles (>18000 citations, h-index 72) with some highlighted in renowned news media (New York Times, Chemistry World, Science Daily, Advanced Science News, and Chemical & Engineering News). He is ranked as the world’s top 2% scientist by Stanford University. He guest-edited a themed issue (“Biomaterials based on phages and other viruses”) in Advanced Drug Delivery Reviews. He has been elected as a fellow of ACS, AAM, RSC, AAAS, AIMBE, BMES, and PMES. He has won multiple awards, such as NSF CAREER Award and the Oklahoma New Scientist Award. He is an associate editor for the new Wiley journal, Biomedical Engineering Materials (BMEMat).